BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18287021)

  • 1. Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.
    Marcondes AM; Mhyre AJ; Stirewalt DL; Kim SH; Dinarello CA; Deeg HJ
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2865-70. PubMed ID: 18287021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
    Li X; Marcondes AM; Gooley TA; Deeg HJ
    Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Cull AH; Mahendru D; Snetsinger B; Good D; Tyryshkin K; Chesney A; Ghorab Z; Reis M; Buckstein R; Wells RA; Rauh MJ
    Leuk Res; 2018 Feb; 65():5-13. PubMed ID: 29227812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IL-32 mRNA Expression of Bone Marrow Stromal Cells and Its Correlation with Cell Apoptosis in Patients with Myelodysplastic Syndrome].
    Zhang YY; Xu L; Li DQ; Shao JH; Chen P; Zhao HY; Dong XB; Gu LP; Wu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):773-8. PubMed ID: 27342508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.
    Mhyre AJ; Marcondes AM; Spaulding EY; Deeg HJ
    Blood; 2009 Jan; 113(3):649-58. PubMed ID: 18945969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bone Marrow Natural Killer Cells (NK); Soluble TNF-α and IL-32 Levels in Myelodysplastic Syndrome Patients.
    Aref S; Khaled N; Al Gilany AH; Ayed M; Abouzeid T; Attia D
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2949-2953. PubMed ID: 33112553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
    Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C
    Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.
    Marcondes AM; Ramakrishnan A; Deeg HJ
    Curr Cancer Ther Rev; 2009 Nov; 5(4):310-314. PubMed ID: 20305828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia.
    Wetzler M; Kurzrock R; Estrov Z; Estey E; Talpaz M
    Leuk Res; 1995 Jan; 19(1):23-34. PubMed ID: 7837815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
    Chamseddine AN; Cabrero M; Wei Y; Ganan-Gomez I; Colla S; Takahashi K; Yang H; Bohannan ZS; Garcia-Manero G
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S67-73. PubMed ID: 27521329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subtype and Functional Biomarker Changes of NK Cells in Peripheral Blood of Patients with Myelodysplastic Syndrome].
    Xu SJ; Shao ZH; Fu R; Wang HQ; Liu H; Liu CY; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):832-836. PubMed ID: 28641645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.
    Carlsten M; Baumann BC; Simonsson M; Jädersten M; Forsblom AM; Hammarstedt C; Bryceson YT; Ljunggren HG; Hellström-Lindberg E; Malmberg KJ
    Leukemia; 2010 Sep; 24(9):1607-16. PubMed ID: 20613786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.
    Kiladjian JJ; Bourgeois E; Lobe I; Braun T; Visentin G; Bourhis JH; Fenaux P; Chouaib S; Caignard A
    Leukemia; 2006 Mar; 20(3):463-70. PubMed ID: 16408099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
    Stirewalt DL; Mhyre AJ; Marcondes M; Pogosova-Agadjanyan E; Abbasi N; Radich JP; Deeg HJ
    Br J Haematol; 2008 Feb; 140(4):444-53. PubMed ID: 18162123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.